P
Pierre Quartier
Researcher at Paris Descartes University
Publications - 66
Citations - 1552
Pierre Quartier is an academic researcher from Paris Descartes University. The author has contributed to research in topics: Canakinumab & Arthritis. The author has an hindex of 19, co-authored 66 publications receiving 1242 citations. Previous affiliations of Pierre Quartier include Necker-Enfants Malades Hospital & University of Paris-Sud.
Papers
More filters
Journal ArticleDOI
Detection of interferon alpha protein reveals differential levels and cellular sources in disease.
Mathieu P Rodero,Jérémie Decalf,Jérémie Decalf,Vincent Bondet,Vincent Bondet,David Hunt,David Hunt,Gillian I. Rice,Scott W Werneke,Scott W Werneke,Sarah McGlasson,Sarah McGlasson,Marie-Alexandra Alyanakian,Brigitte Bader-Meunier,Christine Barnerias,N. Bellon,Alexandre Belot,Christine Bodemer,Christine Bodemer,Tracy A Briggs,Tracy A Briggs,Isabelle Desguerre,Marie-Louise Frémond,Marie Hully,Arn M. J. M. van den Maagdenberg,Isabelle Melki,Isabelle Meyts,Lucile Musset,Nadine Pelzer,Pierre Quartier,Gisela M. Terwindt,Joanna M. Wardlaw,Stewart Wiseman,Frédéric Rieux-Laucat,Frédéric Rieux-Laucat,Yoann Rose,Benedicte Neven,Benedicte Neven,Christina Hertel,Adrian Hayday,Adrian Hayday,Matthew L. Albert,Matthew L. Albert,Flore Rozenberg,Yanick J. Crow,Darragh Duffy,Darragh Duffy +46 more
TL;DR: Measurement of IFN&agr; attomolar concentrations by digital ELISA will enhance the understanding ofIFN biology and potentially improve the diagnosis and stratification of pathologies associated with IFN dysregulation.
Journal ArticleDOI
Clinical outcome in children with chronic recurrent multifocal osteomyelitis
C Catalano-Pons,A Comte,Julien Wipff,Pierre Quartier,Albert Faye,D Gendrel,Agnès Duquesne,Rolando Cimaz,Chantal Job-Deslandre +8 more
TL;DR: Clinical outcome of children with CRMO is generally good, but a sizeable proportion of patients have active disease at follow-up, and a minority of patients can have a severe and prolonged disease course despite intensive treatments.
Journal ArticleDOI
Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency
Caroline Galeotti,Ulrich Meinzer,Pierre Quartier,Linda Rossi-Semerano,Brigitte Bader-Meunier,Pascal Pillet,Isabelle Koné-Paut +6 more
TL;DR: Continuous IL-1 blockade brings substantial benefit to MKD patients and controlled trials are necessary to further assess the clinical benefit and treatment modalities in these patients.
Journal ArticleDOI
The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry
Hermann J. Girschick,Martina Finetti,Francesca Orlando,Susanne Schalm,Antonella Insalaco,Gerd Ganser,Susan Nielsen,Troels Herlin,Isabelle Koné-Paut,Silvana Martino,Marco Cattalini,Jordi Anton,Sulaiman M. Al-Mayouf,Michael Hofer,Pierre Quartier,Christina Boros,Jasmin B Kuemmerle-Deschner,Denise Pires Marafon,Maria Alessio,Tobias Schwarz,Nicolino Ruperto,Alberto Martini,Annette Jansson,Marco Gattorno +23 more
TL;DR: This is the largest reported case series of CNO patients, showing that the range of associated clinical manifestations is rather heterogeneous, and confirms that the disease usually presents with an early teenage onset, but it may also occur in adults, even in the absence of mucocutaneous manifestations.
Journal ArticleDOI
International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor–Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome
Seza Ozen,Jasmin B Kuemmerle-Deschner,Rolando Cimaz,Avi Livneh,Pierre Quartier,Isabelle Koné-Paut,Andrew Zeft,Steve Spalding,Ahmet Gül,Véronique Hentgen,Sinisa Savic,Ivan Foeldvari,Joost Frenkel,Luca Cantarini,Dony Patel,Jeffrey Weiss,Nina Marinsek,R Degun,Kathleen G Lomax,Helen J. Lachmann +19 more
TL;DR: The diagnostic pathway and treatments at tertiary centers for familial Mediterranean fever, tumor necrosis factor receptor–associated periodic syndrome (TRAPS), and mevalonate kinase deficiency/hyperimmunoglobulinemia D syndrome are examined.